Artelo Biosciences Inc.

NASDAQ: ARTL · Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT

Artelo Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
Cash & Equivalents
2.34M 2.81M 6.89M 6.63M
Short-Term Investments
n/a 7.61M 10.64M 3.44M
Long-Term Investments
n/a n/a -1.5M n/a
Other Long-Term Assets
3K 3K 3K 189K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
219K 554K 789K 252K
Total Current Assets
2.56M 10.98M 18.32M 10.32M
Property-Plant & Equipment
99K 21K 60K 90K
Goodwill & Intangibles
2.04M 2.04M 2.04M 2.04M
Total Long-Term Assets
2.14M 2.06M 2.1M 2.32M
Total Assets
4.7M 13.04M 20.42M 12.63M
Account Payables
1.68M 1.24M 905K 493K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 40K 28K
Other Current Liabilities
-3K n/a 53K 5K
Total Current Liabilities
1.77M 1.29M 998K 526K
Long-Term Debt
n/a n/a 23K 67K
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
69K n/a 23K 67K
Total Liabilities
1.84M 1.29M 1.02M 593K
Total Debt
104K 23K 63K 95K
Common Stock
3K 3K 3K 25K
Retained Earnings
-50.14M -40.31M -31.02M -16.9M
Comprehensive Income
-202K -203K -254K 18K
Shareholders Equity
2.86M 11.75M 19.4M 12.04M
Total Investments
n/a 7.61M 9.15M 3.44M